Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats hair loss in transgender men with few side effects.

Pannexin 3 is important for bone formation and the development of bone cells.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

A natural steroid in the body may protect against eye damage in glaucoma.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

Obesity and lifestyle strongly affect heart aging.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

Ultrasound shows 80% of Hidradenitis Suppurativa patients have abnormal hair tracts that may worsen the condition.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Higher aldosterone levels link to hair loss and high blood pressure.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Understanding and tracking our body's natural daily rhythms could help improve heart health.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Adult stem cells are important for tissue repair and have therapeutic potential, but more research is needed to fully use them.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Low prolactin in young women may increase heart and metabolism risks.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.